Item 2.02 Results of Operations and Financial Condition.

On March 12, 2021, PLx Pharma Inc. (the "Company") issued a press release announcing its financial results for its fourth quarter and full fiscal year ended December 31, 2020. The Company's press release is attached hereto as Exhibit 99.1 and the information set forth therein is incorporated herein by reference and constitutes a part of this report.

The information furnished by the Company pursuant to this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liability of that section, and shall not be deemed to be incorporated by reference into any Company filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01 Financial Statements and Exhibits.






(d) Exhibits
    Exhibit No. Description

99.1 Press Release, dated March 12, 2021.

© Edgar Online, source Glimpses